About
About Lyka Labs Limited
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant tablets and combination, proton pump inhibitor, nutraceuticals, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, anti-fungal and bacterial, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. The company offers its products in various forms, including injections, creams, ointments, foams, gels, and lotions. It also exports its products. The company was incorporated in 1976 and is based in Mumbai, India.
Visit company website
5 years, 4 months ago
Lyka Labs Limited is currently in a long term uptrend where the price is trading 74.6% above its 200 day moving average.
From a valuation standpoint, the stock is 74.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.
Lyka Labs Limited's total revenue rose by 46.1% to $268M since the same quarter in the previous year.
Its net income has increased by 94.5% to $-23M since the same quarter in the previous year.
Finally, its free cash flow fell by 28.8% to $35M since the same quarter in the previous year.
Based on the above factors, Lyka Labs Limited gets an overall score of 4/5.